NRX Pharmaceuticals Inc (NRXP)

1.50 -0.02 (-1.32%) USD  |  NASDAQ  |  Dec 20, 16:00
1.50 0.00 (0.00%) After-Hours: 20:00
More

NRX Pharmaceuticals Enterprise Value: 23.16M for Dec. 20, 2024

Enterprise Value Chart

View Enterprise Value for NRXP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Gossamer Bio Inc 60.60M
CEL-SCI Corp 46.19M
AIM ImmunoTech Inc 7.634M
IGC Pharma Inc 27.94M
NovaBay Pharmaceuticals Inc 1.870M

Enterprise Value Related Metrics

Net Income (Quarterly) -1.623M
Total Expenses (Quarterly) 3.022M
EPS Diluted (Quarterly) -0.15
Earnings Yield -588.0%